Updated Jul 16, 2026
Bodaken Bruce G. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Bruce G. Bodaken is a U.S. corporate director with governance experience in the healthcare sector. As of May 2026, he serves as a director of iRhythm Technologies, Inc., a digital health company focused on cardiac monitoring. His broader career has centered on executive leadership and board service across healthcare and technology organizations. Public SEC filings identify him by name as a director for iRhythm Technologies.
| Role | Director |
|---|---|
| Notability | 65/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-29 | IRTC | iRhythm Holdings, Inc. | A — Grant or award | 1.6K | $0.00 |
Bruce G. Bodaken is a U.S. corporate director with governance experience in the healthcare sector. As of May 2026, he serves as a director of iRhythm Technologies, Inc., a digital health company focused on cardiac monitoring. His broader career has centered on executive leadership and board service across healthcare and technology organizations. Public SEC filings identify him …
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bodaken Bruce G. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.